ENTRY       D09612                      Drug
NAME        Eslicarbazepine acetate (USAN);
            Zebinix (TN);
            Aptiom (TN)
PRODUCT     APTIOM (Sunovion Pharmaceuticals)
  GENERIC   ESLICARBAZEPINE ACETATE (Camber Pharmaceuticals)
FORMULA     C17H16N2O3
EXACT_MASS  296.1161
MOL_WEIGHT  296.3205
CLASS       Neuropsychiatric agent
             DG03199  Antiepileptic agent
              DG02034  Carboxamide antiepileptic
            Metabolizing enzyme inhibitor
             DG01933  CYP2C19 inhibitor
            Metabolizing enzyme inducer
             DG02853  CYP3A/CYP3A4 inducer
              DG01635  CYP3A4 inducer
REMARK      ATC code: N03AF04
            Chemical structure group: DG00848
            Product (DG00848): D09612<US>
EFFICACY    Antiepileptic
COMMENT     Carboxamide derivative
            Adjunctive therapy for adults with partial-onset seizures
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04728(6323)  Dopaminergic synapse
INTERACTION CYP inhibition: CYP2C19 [HSA:1557]
            CYP induction: CYP3A4 [HSA:1576]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AF Carboxamide derivatives
                 N03AF04 Eslicarbazepine
                  D09612  Eslicarbazepine acetate (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Sodium Channel Agents
               Eslicarbazepine
                D09612  Eslicarbazepine acetate (USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02034  Carboxamide antiepileptic
                DG00848  Eslicarbazepine
                 D09612  Eslicarbazepine acetate
             Metabolizing enzyme inhibitor
              DG01933  CYP2C19 inhibitor
               DG00848  Eslicarbazepine
                D09612  Eslicarbazepine acetate
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                DG00848  Eslicarbazepine
                 D09612  Eslicarbazepine acetate
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D09612  Eslicarbazepine acetate
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D09612  Eslicarbazepine acetate (USAN) &lt;US&gt;
                SCN2A
                 D09612  Eslicarbazepine acetate (USAN) &lt;US&gt;
                SCN3A
                 D09612  Eslicarbazepine acetate (USAN) &lt;US&gt;
                SCN4A
                 D09612  Eslicarbazepine acetate (USAN) &lt;US&gt;
                SCN5A
                 D09612  Eslicarbazepine acetate (USAN) &lt;US&gt;
                SCN8A
                 D09612  Eslicarbazepine acetate (USAN) &lt;US&gt;
                SCN9A
                 D09612  Eslicarbazepine acetate (USAN) &lt;US&gt;
                SCN10A
                 D09612  Eslicarbazepine acetate (USAN) &lt;US&gt;
                SCN11A
                 D09612  Eslicarbazepine acetate (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09612
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09612
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09612
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09612
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02034  Carboxamide antiepileptic
                DG00848  Eslicarbazepine
             Metabolizing enzyme inhibitor
              DG01933  CYP2C19 inhibitor
               DG00848  Eslicarbazepine
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                DG00848  Eslicarbazepine
DBLINKS     CAS: 236395-14-5
            PubChem: 124490352
            LigandBox: D09612
ATOM        22
            1   C8y C    22.4000  -25.4100
            2   N1y N    23.6600  -24.7800
            3   C8y C    24.9200  -25.4100
            4   C8y C    25.2000  -26.7400
            5   C8y C    22.1200  -26.8100
            6   C1x C    24.3600  -27.8600
            7   C1y C    22.9600  -27.8600
            8   C8x C    21.3500  -24.4300
            9   C8x C    20.0200  -24.9200
            10  C8x C    19.7400  -26.2500
            11  C8x C    20.7900  -27.2300
            12  C8x C    26.6000  -27.0900
            13  C8x C    27.5800  -26.1100
            14  C8x C    27.2300  -24.7800
            15  C8x C    25.8300  -24.3600
            16  C5a C    23.6600  -23.3800
            17  O5a O    22.4700  -22.6800
            18  N1a N    24.8500  -22.6800
            19  O7a O    22.3300  -29.1200
            20  C7a C    20.9300  -29.1200
            21  O6a O    20.2300  -27.9076
            22  C1a C    20.2300  -30.3324
BOND        24
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     1   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    5  11 2
            13    4  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17   15   3 2
            18    2  16 1
            19   16  17 2
            20   16  18 1
            21    7  19 1 #Down
            22   19  20 1
            23   20  21 2
            24   20  22 1
///
